Frontline Summer 2013

​A Game-Changer The Personal Cancer Genome and Precision Cancer Trials By SAMEEK ROYCHOWDHURY, MD, PhD, assistant professor of Internal Medicine and of PharmacologyClinical trials traditionally have been designed to treat patients with a ...[Read more]
Published: Jul-30-13 | 28  Comments | 0  Link to this post

Of Note – Recent recognitions of OSUCCC-James physicians and researchers

AWARDS AND RECOGNITIONS Richard Burry, director of the OSUCCC Microscopy shared resource and the Campus Microscopy and Imaging Facility, has received the Carpenter-Rasch Award from The Histochemical Society. Burry (standing left) was recognized ...[Read more]
Published: Jan-13-10 | 65  Comments | 0  Link to this post

Fractionating Forests – Discovering promising anitcancer agents requires experience and the science of pharmacognosy

Douglas Kinghorn, PhD, DSc, Jack Beal Professor and Chair of Natural Products Chemistry and Pharmacognosy in the College of Pharmacy By Darrell E. Ward photography by Roman Sapecki In August 2000, Drs. Soedarsono Riswan and Leonardus B.S. Kard ...[Read more]
Published: Jan-13-10 | 53  Comments | 0  Link to this post

Bench to Bedside

OSU 08173 – A Randomized, Double-Blind, Multi-Center, Phase III Study of Brivanib Plus Best Supportive Care versus Placebo Plus Best Supportive Care in Subjects with Advanced Hepatocellular Carcinoma (HCC) Who Have Failed or Are Intolerant to Sorafe ...[Read more]
Published: Jan-13-10 | 3  Comments | 0  Link to this post